everydayhealth.com
Mar 30, 2025, 12:49
Overcoming Stage IV Melanoma with Innovative Treatment and Expert Care – SCRI
Sarah Cannon Research Institute (SCRI) posted on LinkedIn:
“Introducing Ivy, a remarkable woman from Mississippi whose battle with stage IV malignant melanoma brought her to SCRI Oncology Partners.
Under the care of Dr. Meredith McKean, Ivy participated in a clinical trial that targeted her specific genetic mutations. Her determination, combined with expert care, led to her being cancer-free and enjoying life with her family.
Ivy’s journey underscores the impact of innovative cancer treatments and the dedication of our healthcare professionals.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 21, 2025, 20:46
Apr 21, 2025, 20:30
Apr 21, 2025, 20:11
Apr 21, 2025, 19:55
Apr 21, 2025, 19:12
Apr 21, 2025, 18:19